<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: Drugs - Generic Industry News</title><link>http://biz.yahoo.com/ic/news/512.html</link><description>The latest news on the Drugs - Generic industry from Yahoo! Finance</description><language>en-us</language><lastBuildDate>Thu, 2 Jul 2009 16:44:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>Cannabis Science Enters into Investor Relations Agreement (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090702/20090702005580.html?.v=1</link><description>SAN FRANCISCO----Cannabis Science Inc. , an emerging cannabis pharmaceutical company, is pleased to announce that the company has retained Catalyst Xchange Corp. , located in London, Ontario, to provide it with investor relations services under an agreement dated June 30, 2009.</description><guid isPermaLink="false">yahoo_finance/2731584235</guid><pubDate>Thu, 2 Jul 2009 16:44:00 Etc/GMT</pubDate></item><item><title>Mylan Expands into Biologics Space (Zacks.com)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/090701/21708.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/96556199</guid><pubDate>Wed, 1 Jul 2009 16:37:07 Etc/GMT</pubDate></item><item><title>Watson Pharmaceuticals Appoints Christopher W. Bodine to Board of Directors (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090629/la38589.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4136226627</guid><pubDate>Mon, 29 Jun 2009 12:00:00 Etc/GMT</pubDate></item><item><title>Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090629/ne38983.html?.v=1</link><description>Mylan Inc. today announced that it has executed a definitive agreement with Biocon Limited, a publicly traded company on the Indian stock exchanges, for an exclusive collaboration on the development, manufacturing, supply and commercialization of multiple, high value generic biologic compounds for the global marketplace.</description><guid isPermaLink="false">yahoo_finance/2792377335</guid><pubDate>Mon, 29 Jun 2009 10:30:00 Etc/GMT</pubDate></item><item><title>[$$] Biocon Signs Pact With Mylan (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=11rckvbbi/*http%3A//online.wsj.com/article/SB124625349384967451.html?ru=yahoo#mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/1101869362</guid><pubDate>Mon, 29 Jun 2009 09:37:04 Etc/GMT</pubDate></item><item><title>Caraco Pharmaceutical Laboratories, Ltd. Updates on Financial Position (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090626/de38704.html?.v=1</link><description>Caraco Pharmaceutical Laboratories, Ltd. , in an effort to update our shareholders, is providing additional information in regards to our financial position in light of the recent FDA action.</description><guid isPermaLink="false">yahoo_finance/3446801651</guid><pubDate>Fri, 26 Jun 2009 13:15:00 Etc/GMT</pubDate></item><item><title>[$$] Sun Pharma Awaits Clarity on FDA Move, Shares Slide (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=11r0us6hp/*http%3A//online.wsj.com/article/SB124599890667059345.html?ru=yahoo#mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/1581470286</guid><pubDate>Fri, 26 Jun 2009 07:01:04 Etc/GMT</pubDate></item><item><title>Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Action (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090625/de38663.html?.v=1</link><description>Caraco Pharmaceutical Laboratories, Ltd. announced that U.S. Marshals, at the request of the Food and Drug Administration, today arrived and seized drug products manufactured in its Michigan facilities.</description><guid isPermaLink="false">yahoo_finance/1659076108</guid><pubDate>Fri, 26 Jun 2009 02:09:00 Etc/GMT</pubDate></item><item><title>Caraco Stock Plunges On FDA Raid, Seizure (at TheStreet.com)</title><link>http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=132vovt48/*http%3A//www.thestreet.com/_yahoo/story/10527699/1/caraco-stock-plunges-on-fda-raid-seizure.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NA</link><description></description><guid isPermaLink="false">yahoo_finance/4071725450</guid><pubDate>Thu, 25 Jun 2009 20:20:56 Etc/GMT</pubDate></item><item><title>A New Audio Interview Featuring Cannabis Science CEO, Steve Kubby, is Now at SmallCapVoice.com (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090625/20090625005288.html?.v=1</link><description>AUSTIN, Texas----SmallCapVoice.com, Inc. announced today that a new audio interview profiling the San Francisco California based company, Cannabis Science Inc. , an emerging pharmaceutical cannabis company, is now available.</description><guid isPermaLink="false">yahoo_finance/3580423120</guid><pubDate>Thu, 25 Jun 2009 13:30:00 Etc/GMT</pubDate></item><item><title>FDA Approves Generic Version of Plan B (at The Wall Street Journal Online)</title><link>http://us.rd.yahoo.com/finance/external/wsj/rss/SIG=12ii7c32t/*http%3A//online.wsj.com/article/SB10001424052970203937504574248384059754024.html?ru=yahoo#mod=yahoo_hs</link><description></description><guid isPermaLink="false">yahoo_finance/4151579169</guid><pubDate>Wed, 24 Jun 2009 22:55:05 Etc/GMT</pubDate></item><item><title>Watson gets FDA approval for generic Plan B (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090624/us_watson_pharmaceuticals_fda.html?.v=2</link><description>Watson Pharmaceuticals Inc. said Wednesday it recieved Food and Drug Administration approval for a generic version of Duramed Pharmaceuticals&apos; Plan B emergency contraceptive.</description><guid isPermaLink="false">yahoo_finance/3708007947</guid><pubDate>Wed, 24 Jun 2009 22:06:35 Etc/GMT</pubDate></item><item><title>Watson Pharmaceuticals Receives FDA Approval For Generic PLAN B(R) (PR Newswire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/090624/la37939.html?.v=1</link><description>Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, today announced that its subsidiary, Watson Laboratories, Inc., has received approval today from the United States Food and Drug Administration on its Abbreviated New Drug Application for levonorgestrel tablets, 0.75 mg, for women seventeen years and younger.</description><guid isPermaLink="false">yahoo_finance/246362670</guid><pubDate>Wed, 24 Jun 2009 21:48:00 Etc/GMT</pubDate></item><item><title>SeraCare Life Sciences Launches First-to-Market HPV Genotype Performance Panel (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090624/20090624005282.html?.v=1</link><description>MILFORD, Mass.----SeraCare Life Sciences, Inc. today announced that the Company has launched a new product in its diagnostic controls and panels portfolio--the SeraCare Human Papillomavirus Genotype Performance Panel.</description><guid isPermaLink="false">yahoo_finance/1583107192</guid><pubDate>Wed, 24 Jun 2009 12:03:00 Etc/GMT</pubDate></item><item><title>Pro-Pharmaceuticals&apos; Chief Scientist Published Articles in Three Prestigious Peer-Reviewed Journals (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090624/20090624005280.html?.v=1</link><description>NEWTON, Mass.----Pro-Pharmaceuticals, Inc. , a developer of carbohydrate-based targeted therapeutic compounds to treat cancer and fibrosis, today announced that its Chief Scientist and co-founder, Anatole Klyosov, Ph.D., published articles in: the Biochemical Journal, Carbohydrate Research and Glycobiology that further define the mechanism of action of its lead compound DAVANAT® and the role it plays in the treatment of cancer.</description><guid isPermaLink="false">yahoo_finance/1649877558</guid><pubDate>Wed, 24 Jun 2009 11:00:00 Etc/GMT</pubDate></item><item><title>Jury to be picked for Alabama drug pricing lawsuit (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090623/us_alabama_drug_suits_preview.html?.v=1</link><description>Attorneys are set to pick a jury Tuesday to hear Alabama&apos;s lawsuit against prescription drug manufacturer Watson Pharmaceuticals of Corona, Calif.</description><guid isPermaLink="false">yahoo_finance/503902954</guid><pubDate>Tue, 23 Jun 2009 15:31:43 Etc/GMT</pubDate></item><item><title>Par announces mixed offering for $150 million (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090619/us_par_stock_offering.html?.v=2</link><description>Par Pharmaceutical Cos. said Friday it is selling up to $150 million in a mixed shelf offering and plans to use the proceeds for general corporate purposes.</description><guid isPermaLink="false">yahoo_finance/1798858261</guid><pubDate>Fri, 19 Jun 2009 20:49:08 Etc/GMT</pubDate></item><item><title>Watson to Present at Wachovia&apos;s 19th Annual Mid-Year Equity Conference (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090618/0512055.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/970367635</guid><pubDate>Thu, 18 Jun 2009 18:27:00 Etc/GMT</pubDate></item><item><title>Watson Pharmaceuticals rises after Arrow buyout (AP)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/090618/us_watson_pharmaceuticals_mover.html?.v=1</link><description>Shares of Watson Pharmaceuticals Inc. advanced Thursday, a day after the generic drugmaker moved to boost its U.S. sales and expand its international presence by buying Arrow Group.</description><guid isPermaLink="false">yahoo_finance/2294203289</guid><pubDate>Thu, 18 Jun 2009 16:17:47 Etc/GMT</pubDate></item><item><title>Cannabis Science Development Team Recommends Patent Filings for Its Cannabis Processing and Drug Delivery Systems (Business Wire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/090618/20090618005745.html?.v=1</link><description>SAN FRANCISCO----Cannabis Science Inc. , an emerging pharmaceutical cannabis company, announced today that patent filings are expected for two of its key innovations. &quot;The Drug Development Team members recognize the importance of having our first cannabis-based medicine covered, not just by one patent, but by two,&quot; Dr.</description><guid isPermaLink="false">yahoo_finance/1887534364</guid><pubDate>Thu, 18 Jun 2009 16:06:00 Etc/GMT</pubDate></item></channel></rss><!-- c49.finance.mud.yahoo.com compressed/chunked Sun Jul  5 19:26:56 PDT 2009 -->
